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1. Introduction  
The use of 31P-magnetic resonance (MR) spectroscopy (31P-MRS) allows noninvasive 
measurement of high-energy phosphate compounds such as phosphocreatine (PCr) and 
adenosine triphosphate (ATP), and the low-energy breakdown product, inorganic 
phosphate (Pi), in exercising muscle. Ratios of measureable high- and low-energy 
phosphate metabolites (e.g., PCr/Pi or PCr/(PCr+Pi) have been utilized as indices of the 
overall bioenergetic state of the cell (Sapega et al., 1987). Extracellular Pi does not exist in 
sufficient quantities to significantly affect 31P-MR spectra (Sapega et al., 1987). 
Intracellular pH (pHi) can also be measured noninvasively based on the pH-dependent 
chemical shift of cellular Pi that appears as PCr peaks on 31P-MRS (Sapega et al., 1987; 
Taylor et al., 1983). A decrease in pHi during exercise suggests lactate accumulation in 
muscles (Sapega et al., 1987; Taylor et al., 1983). 
We have previously found, using 31P-MRS, that skeletal muscle metabolism in patients with 
chronic respiratory impairment undergoes specific changes (Kutsuzawa et al., 1992, 1995). 
Patients with chronic respiratory impairment display significant decreases in PCr and pHi 
during even mild exercise, suggesting that ATP production is reduced and that lactate levels 
accumulate rapidly in their muscles, suggesting reduced oxidative capacity. In addition, 
recent studies have demonstrated that reduced oxidative capacity in skeletal muscles 
correlates with an accelerated lactate response to exercise in patients with chronic 
obstructive pulmonary disease (COPD) (Maltais et al., 1996; Saey et al., 2005). Several factors 
such as inactivity, malnutrition and/or hypoxemia might contribute to altered muscle 
metabolism (Mannix et al., 1995; Payen et al., 1993; Sala et al., 1999). 
Weight loss and muscle wasting are common features in patients with COPD (Bernard et al., 
1998) and muscle wasting contributes to muscle weakness and exercise limitations in 
patients with COPD (Schols et al., 1993). Skeletal muscle is the major protein store that 
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supplies amino acids to other tissues under specific conditions. Plasma concentrations of 
free amino acids indicate the balance between exogenous uptake and intercurrent 
metabolites in protein synthesis and breakdown (Wagenmakers, 1998). The branched-chain 
amino acids (BCAAs) leucine, isoleucine, and valine account for 35% of the essential amino 
acids contained in muscle proteins (Harper et al., 1984). Although essential amino acids 
other than BCAAs are mainly catabolized in the liver, BCAAs can be oxidized in skeletal 
muscle (Wagenmakers, 1998). 
Several investigators have reported that the amino acid profile is altered in the plasma and 
skeletal muscle of patients with COPD (Engelen et al., 2000b; Hoffored et al., 1990; Pouw et 
al., 1998; Yoneda et al., 2001). Most of these studies have shown that plasma concentrations 
of the BCAAs leucine, isoleucine, and valine are reduced (Engelen et al., 2000b; Hoffored et 
al., 1990; Yoneda et al., 2001). Yoneda et al. (Yoneda et al., 2001) demonstrated that 
decreased concentrations of BCAAs in COPD are specifically related to weight loss and 
decreased muscle mass. 
Energy expenditure greatly increases in skeletal muscle during exercise, and BCAA 
oxidization then maximally increases two- to three-fold (Knapik et al., 1991; Wolf et al., 
1982). In addition, BCAAs might contribute to energy metabolism during exercise as 
substrates that expand the pool of tricarboxylic acid (TCA) cycle intermediates 
(Wagenmakers, 1998). Using 31P-MRS, we have previously found that plasma concentrations 
of BCAAs correlate with muscle pH at the completion of exercise in patients with COPD 
(Kutsuzawa et al., 2009). Those findings were consistent with a role of BCAAs in muscle 
energy metabolism during exercise in patients with COPD. 
Supplementation with amino acids, particularly BCAAs, should increase exercise capacity 
in COPD patients, who might be affected by altered muscle and plasma amino acid 
profiles. Several studies in healthy subjects have examined the effects of BCAA ingestion 
on lactate metabolism during long-term, exhaustive exercise (De Palo et al., 2001; 
MacLean et al., 1996; Vukovich et al., 1992). MacLean et al. (MacLean et al., 1996) 
examined the effects of a large oral dose (308 mg/kg) of BCAAs on muscle amino acid 
metabolism during 90 min of exercise. They found that lactate release and arterial lactate 
values were lower in the group given BCAAs compared to a control group. We have 
studied the effects of BCAA ingestion on muscle pH during repeated bouts of short-term 
(3-min) exercise in healthy subjects and have found that BCAA supplementation before 
exercise can cause the attenuation of acidosis in exercising muscle, probably due to a 
decrease in lactate production (Kutsuzawa et al., 2011). Another study (Doi et al., 2004) of 
muscle energy metabolism demonstrated that an infusion of glucose and BCAAs before 
exercise improved acidic pHi during exercise in patients with liver cirrhosis accompanied 
by a severe amino acid imbalance.  
The effects of BCAA ingestion on muscle pH have been investigated in healthy young 
participants (Kutsuzawa et al., 2011), but whether such supplementation will benefit 
exercise capacity in patients with COPD remains unclear. We thus used 31P-MRS to 
investigate the effects of BCAA ingestion on muscle pH during repeated bouts of short-term 
(3-min) exercise. Our hypothesis was that BCAA ingestion before a second bout of exercise 
could prevent metabolic acidosis in exercising muscle. 
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2. Methods 
2.1 Subjects 
Subjects comprised 10 ambulatory male outpatients with stable COPD (mean age, 70.4 ± 8.8 
years) diagnosed according to spirometric findings from moderate to very severe airflow 
limitation (forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC)<70% and 
FEV1 <80% of the predicted value) (Global Initiative for Chronic Obstructive Lung Disease, 
2010). None of the patients had ever received systemic corticosteroid therapy and two of 
them had been treated with oxygen inhalation at home.  None of them had participated in 
pulmonary rehabilitation. Exclusion criteria were malignancy, cardiac failure, renal failure, 
liver cirrhosis, diabetes mellitus, and infection. The ethics committee at our institution 
approved the study protocol, and both the control individuals and patients provided 
written informed consent to participate. Tables 1 and 2 show the physical characteristics of 
the participants. 
 
  Patients (n=10) 
Age years 70.4 ± 8.8 
Height cm 163.9 ± 3.8 
Weight kg 55.6 ± 10.0 
BMI kg/m2 20.6 ± 3.1 
Forearm circumference cm 22.9 ± 1.7 
TSF cm 5.6 ± 3.0 
Grip power (left) kg 36.7 ± 5.5 
Table 1. Anthropometric data from the patients. Values are given as mean ± SD. BMI, body 
mass index; TSF, triceps skinfold thickness. 
 
  Patients (n=10) 
VC L 2.75 ± 0.77 
VC (%of predicted) % 84.1 ± 21.8 
FEV1 L 1.02 ± 0.40 
FEV1/FVC % 40.3 ± 9.4 
FEV1 (% of predicted) % 41.5 ± 15.4 
pH  7.412 ± 0.031 
PaCO2 Torr 41.3 ± 4.8 
PaO2 Torr 79.8 ± 7.6 
Table 2. Spirometric and blood gas analysis data from the patients. Values are given as mean 
± SD. VC, vital capacity; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; 
PaCO2, partial pressure of CO2; PaO2, partial pressure of O2. 
2.2 Study design 
All patients fasted overnight, then anthropometric parameters and grip strength were 
measured at our outpatient clinic. Maximal voluntary grip strength of the non-dominant 
arm was measured using a dynamometer (DM-100N; Yagami, Nagoya, Japan). Fasting 
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venous blood was obtained from an antecubital vein. Arterial blood was taken from the 
brachial artery for blood gas analysis while breathing room air. 
All patients then performed two consecutive, 3-min constant work-rate exercises (a control 
bout and a BCAA bout), using the non-dominant forearm. Differences in MRS variables 
among individuals might be smaller for the non-dominant arm because routine activities 
might not vary as much as those performed with the dominant arm. Ten minutes after the 
first bout (control bout) of exercise, the patients consumed 8.0 g of powdered BCAAs (2 
packs of LIVACT®; Ajinomoto, Tokyo, Japan) with 100 ml of water. The second bout (BCAA 
bout) of exercise started at 60 min after BCAA ingestion. Patients remained seated during 
the interval between first and second bouts of exercise and were allowed water. Muscle 
metabolism was measured using 31P-MRS during 1.5 min of rest, 3 min of exercise, and 4 
min of recovery. 
The exercise consisted of repetitively gripping a lever attached to a weight via a pulley 
system at a rate of 20 grips/min for 3 min while supine and breathing room air. The 
weight was lifted 5 cm by gripping the lever. To normalize the exercise intensity, the 
weight was adjusted to 7% of the maximum grip strength, which was suitable for this 
study because all patients could complete the exercise. Moreover, repetitive hand-
gripping exercise in which the same weight (7% of maximal hang grip) is lifted 5 cm 20 
times per min can differentiate healthy from altered muscle metabolism (as a decrease in 
pHi) (Kutsuzawa et al., 1992, 1995). 
2.3 BCAA supplementation 
LIVACT® is a BCAA powder that was developed to treat imbalances in amino acids among 
patients with liver cirrhosis. One pack of LIVACT (4.75 g) contains 4.0 g of BCAA (3808 mg 
of leucine, 1904 mg isoleucine and 2288 mg of valine). The composition ratio of leucine, 
isoleucine and valine at 2:1:1.2 effectively balances nitrogen as well as the plasma amino 
acid profile (Ohashi et al., 1989). The plasma BCAA level at 2 h after ingesting 8 g of BCAA 
increases 2-fold (Hamada et al., 2005). 
2.4 Nutritional assessment 
Nutritional status was evaluated by biochemical blood testing and anthropometric 
measurements including height, weight, non-dominant forearm circumference and triceps 
skin fold thickness (TSF). Body mass index (BMI) was calculated based on height and 
weight. The circumference of the non-dominant forearm was measured at the proximal 
third of the forearm, where the MRS surface coil was positioned. TSF of the non-dominant 
arm was measured using an EIYOKEN-TYPE skinfold caliper (Yagami). 
Fasting blood samples from all patients were obtained by venipuncture before the control 
bout. In six of the 10 patients, second blood samples were obtained before the BCAA bout. 
Portions of samples were immediately cooled on ice and plasma obtained by 
centrifugation at 4C was stored at -80C for later amino acid analysis. Samples were 
deproteinized using 5% sulfosalicylic acid, then plasma levels of amino acids were 
measured by ion-exchange, high-pressure liquid chromatography with fluorometric 
detection (Model 8500; Hitachi, Tokyo, Japan) (Dyel et al., 1986). Total BCAAs comprised 
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leucine + isoleucine + valine, and total amino acids included all measured amino acids. 
Serum albumin and prealbumin, as indices of nutritional status, were determined by 
routine methods in other portions of the samples. 
2.5 
31
P-MRS 
Unlocalized MR spectra were obtained using a 2.0-T, 31-cm-bore BEM 250/80 
superconducting magnet (Otsuka Electronics Co., Osaka, Japan). The spectrometer was 
operated at 85 MHz for 1H and at 34.5 MHz for 31P. A 4-cm surface coil was placed on the 
proximal third of the non-dominant forearm. We accumulated 31P-MR spectra every 3 s for 1 
min using a single 90 pulse (50 μs) (Kutsuzawa et al., 1992). We then analyzed the 31P-MR 
spectrum at rest (1 min before onset of exercise) and at the end of 3 min of exercise. 
The signal area for Pi and PCr was determined from each spectrum by Gaussian curve 
fitting (Kutsuzawa et al., 1992). Relative concentrations of PCr and Pi were evaluated using 
normalized units of PCr/(PCr+Pi). 
Muscle pH (i.e., pHi) was calculated as a difference in the chemical shift between Pi and the 
PCr peak (Stevens, 1987; Taylor et al., 1983). At physiological pH, Pi exists as HPO42- and 
H2PO4- ions. The signal from HPO42- is shifted downfield by 2.25 ppm from that of H2PO4-. 
However, the two forms are in rapid exchange, so a single Pi peak is formed with a chemical 
shift reflecting the relative proportions of the two ions. The chemical shift in Pi can thus be 
used as a pH indicator, as follows: 
pH = 6.75 + log (δ – 3.27)/(5.69 – δ), 
where δ is the difference of chemical shift in parts per million between the Pi and PCr 
signals (Taylor et al., 1983). The pH was determined from the weighted average of both Pi 
peaks if the peak was split. 
We determined ∆pHi or ∆PCr/(PCr+Pi) as the difference between values just before and at 
the end of the exercise period. 
2.6 Statistical analysis 
All data are presented as means  standard deviation (SD). MRS variables between the 
control and BCAA bouts of exercise and between resting and the end of exercise were 
compared using Student’s paired t-test. The ∆pHi and ∆PCr/(PCr+Pi) between control and 
BCAA bouts were compared to determine the effects of BCAA supplementation using the 
paired Student’s t-test. We used linear regression analysis to evaluate correlations between 
concentration of BCAA and BMI, between BCAA and spirometric data, and between BCAA 
and the MRS variable (∆pHi of the first exercise bout) using the least-squares method. 
Goodness of fit was examined using the χ2-test. A value of p < 0.05 was considered 
indicative of a significant difference. 
3. Results 
3.1 Physical characteristics and nutritional assessment 
Table 1 shows the physical characteristics of the 10 patients. Mean body mass index of 
patients was 20.6 ± 3.1 kg/m2 and 3 of the patients were considered malnourished (BMI < 
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20). Table 2 shows spirometric data from the patients with COPD. Mean FEV1 was 1.02 ± 
0.40 L. Based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria 
(Global Initiative for Chronic Obstructive Lung Disease, 2010), 3 of the 10 patients were 
categorized as stage II, 4 as stage III and 3 as stage IV, but none showed severe hypoxemia 
(partial pressure of O2 (PaO2), 79.8 ± 7.6 Torr). 
3.2 Nutritional assessment 
Values of serum albumin did not decrease in the patients. Although the mean level of 
prealbumin was within normal range (22-40 mg/dl), two of the patients showed a 
prealbumin level below the lower limit of the normal range (Table 3). 
 
  Patients (n=10) 
Albumin g/dl 4.5 ± 0.4 
Prealbumin mg/dl 25.9 ± 6.5 
Table 3. Albumin and prealbumin levels in fasting venous blood from patients. Values are 
given as mean ± SD. 
 
Amino acid (nmol/L) Range Patients (n=10) 
Taurine 40 - 93 56.4 ± 14.8 
Threonine 67 - 190 101.5 ± 21.0 
Serine 72 - 190 92.1 ± 20.8 
Asparagine 45 - 97 43.1 ± 8.5 
Glutamic acid 12 - 63 38.1 ± 12.0 
Glutamine 420 - 700 699.5 ± 146.1 
Proline 78 - 270 132.2 ± 35.1 
Glycine 150 - 350 167.9 ± 40.6 
Alanine 210 - 520 339.5 ± 55.0 
Citrulline 17 - 43 36.5 ± 14.7 
Aminobutyric acid 7.9 - 27 13.2 ± 4.1 
Valine 150 - 310 199.9 ± 34.6 
Cystine 29 - 49 49.4 ± 8.2 
Methionine 19 - 40 23.7 ± 5.2 
Isoleucine 40 - 110 59.4 ± 12.8 
Leucine 48 - 180 103.2 ± 21.6 
Tyrosine 40 - 90 65.2 ± 13.8 
Phenylalanine 43 - 76 56.8 ± 11.2 
Histidine 59 - 92 70.7 ± 12.7 
Tryptophan 37 - 75 58.6 ± 9.3 
Ornithine 30 - 100 53.1 ± 16.3 
Lysine 110 - 240 191.5 ± 47.8 
Arginine 54 - 130 100.1 ± 28.7 
Total amino acids 2100 - 3500 2770.7 ± 391.8 
Total BCAAs 270 - 600 362.4 ± 66.4 
Table 4. Plasma amino acid concentrations before the first exercise bout. Values are given as 
mean ± SD. BCAA, branched-chain amino acid.  
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Table 4 shows values for individual plasma amino acids. Total amino acids and total BCAAs 
were not reduced from the normal range. The mean glutamine concentration was 
approximately at the upper limit of the normal range. Concentrations of total BCAAs tended 
to correlate with BMI (r = 0.6099, p < 0.1) in patients. Concentrations of total BCAAs did not 
correlate with FEV1(%of the predicted value), which is an index of COPD severity. 
Plasma amino acid profiles at 1 h after BCAA ingestion were examined in 6 of 10 patients 
(Table 5). Valine, leucine, and isoleucine significantly increased by more than 3- to 5-times 
after BCAA ingestion. Glutamine and arginine were also slightly but significantly increased.  
 
Amino acid (nmol/L) 
Fasting After BCAA ingestion 
(n=6) 
Taurine 51.7 ± 6.0 52.6 ± 3.8 
Threonine 112.4 ± 15.6 110.8 ± 19.4 
Serine 101.7 ± 18.1 104.7 ± 20.5 
Asparagine 45.5 ± 8.6 43.5 ± 7.3 
Glutamic acid 32.6 ± 11.5 31.3 ± 14.2 
Glutamine 749.2 ± 165.0 889.4 ± 167.4** 
Proline 133.8 ± 20.1 116.9 ± 23.2* 
Glycine 210.8 ± 47.7 190.7 ± 48.6* 
Alanine 351.1 ± 67.1 315.5 ± 42.7 
Citrulline 40.8 ± 16.6 39.6 ± 18.0 
Aminobutyric acid 14.6 ± 3.7 15.3 ± 3.4 
Valine 203.3 ± 22.9 679.8 ± 160.1** 
Cystine 51.0 ± 6.4 51.0 ± 5.6 
Methionine 25.1 ± 4.6 22.9 ± 4.2 
Isoleucine 59.2 ± 12.2 322.6 ± 83.6** 
Leucine 103.6 ± 19.0 606.5 ± 163.1** 
Tyrosine 66.0 ± 14.9 61.5 ± 12.0 
Phenylalanine 56.6 ± 9.8 53.0 ± 6.7 
Histidine 74.2 ± 10.8 77.7 ± 10.4 
Tryptophan 60.0 ± 9.1 53.4 ± 8.8** 
Ornithine 59.0 ± 17.1 59.3 ± 17.7 
Lysine 216.8 ± 29.2 232.4 ± 38.6 
Arginine 111.1 ± 29.7 128.1 ± 36.3* 
Total amino acids 2918.4 ± 332.0 4246.0 ± 320.3** 
Total BCAAs 366.0 ± 51.5 1609.0 ± 386.9** 
Table 5. Plasma amino acid concentration before and after ingestion of BCAAs. Valine, 
leucine, and isoleucine were increased more than 300% by 1 h after BCAA ingestion. Values 
are given as mean ± SD. *: p < 0.05 vs. before ingestion; **: p < 0.01 vs. before ingestion. 
3.3 Muscle energy metabolism 
Representative 31P-MR spectra obtained from a 75-year-old patient with COPD at the end of 
exercise are shown in Figure 1. The peak for Pi was higher than that for PCr, and shifted 
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toward that of PCr during the control bout of exercise (Fig. 1A). In contrast, the peak of Pi was 
lower than that of PCr, and the Pi peak went back toward the normal chemical shift (-4.9 ppm). 
The values of pHi were calculated as 6.39 (Fig. 1A) and 6.84 (Fig. 1B) during the control and 
BCAA bouts of exercise, respectively. Values of PCr/(PCr+Pi) during the control (Fig. 1A) and 
BCAA bout (Fig. 1B) of exercise were 0.467 (Fig. 1A) and 0.630 (Fig. 1B), respectively. 
-10 -5 0 5 10 15 20 25 
Pi
B
-10 -5 0 5 10 15 20 25 
PCr
PCr
Pi
A
 
         Chemical Shift (ppm)             Chemical Shift (ppm) 
Fig. 1. 31P-MR spectra after 3 min of exercise, obtained from a 75-year-old patient with 
COPD. A and B, First (control) and second (after BCAA ingestion) bouts of exercise, 
respectively; Pi, inorganic phosphate; PCr, phosphocreatine. 
Calculated values of pHi and PCr/(PCr+Pi) in the control bout of exercise were 6.39 and 
0.467, respectively, and those in the BCAA bout were 6.84 and 0.630, respectively. 
Mean values of pHi and PCr/(PCr+Pi) at rest and at the end of each exercise are shown in 
Tables 6 and 7, respectively. Both pHi and PCr/(PCr+Pi) were significantly decreased at the 
end of each exercise bout. Mean values for pHi and PCr/(PCr+Pi) were significantly higher 
at the end of the BCAA bout than at the end of the control bout. Thus, ∆pHi and 
∆PCr/(PCr+Pi) were significantly smaller in the BCAA bout. In addition, acidic changes in 
pHi were attenuated in 6 of the 10 patients in the BCAA bout (Fig. 2). 
 
 Control bout BCAA bout 
At rest 7.00 ± 0.08 7.03 ± 0.09 
End of exercise 6.70 ± 0.19 # 6.86 ± 0.14 * † 
∆pH -0.31 ± 0.19 -0.17 ± 0.17 * 
Table 6. Changes in muscle pH. *, p < 0.05 vs. control bout; †, p < 0.05 vs. resting; #, p < 0.01 
vs. resting. ∆pH, difference in pHi between resting and end of exercise. 
 
 Control bout BCAA bout 
At rest 0.870 ± 0.023 0.876 ± 0.032 
End of exercise 0.423 ± 0.056 0.502 ± 0.103 * # 
∆PCr/(PCr+Pi) -0.447 ± 0.059 # -0.373 ± 0.094 * 
Table 7. Changes in PCr/(PCr+Pi). *, p < 0.05 vs. control bout; #, p < 0.01 vs. resting. 
∆PCr/(PCr+Pi), difference in PCr/(PCr+Pi) between resting and end of exercise. 
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The pHi of all participants in the control bout of exercise correlated with leucine 
concentration (r=0.6713) and tended to correlate with BCAA concentration (r=0.6015). 
-0.6
-0.4
-0.2
0
? PCr/(PCr+Pi)
Control bout BCAA bout
-0.8 
-0.6 
-0.4 
-0.2 
0.0 
? pHi
Control bout BCAA bout
 
Fig. 2. Differences in pHi (∆pHi) and PCr/(PCr+Pi) (∆PCr/(PCr+Pi)) of each patient in 
control and BCAA bout. Six of 10 patients showed that ∆pHi and ∆PCr/(PCr+Pi) were 
reduced in the BCAA bout. 
4. Discussion 
We investigated the acute effects of a single BCAA ingestion on muscle energy metabolism 
during hand-grip exercise in patients with COPD and found a decrease in ∆pHi and 
∆PCr/(PCr+Pi) for the BCAA bout. The finding suggests that BCAA supplementation 
before exercise can cause an attenuation of acidosis in exercising muscle among COPD 
patients, probably due to an increase in oxidative capacity and a decrease in lactate 
production. 
4.1 Muscle pH 
Values of pHi can be measured using 31P-MRS as the pH-dependence of a chemical shift 
between cellular Pi and PCr peaks (Sapega et al., 1987; Taylor et al., 1983). In addition, pHi 
can be determined as the H+ balance of consumption (PCr hydrolysis, buffering capacity 
and H+ efflux) and lactate production processes (Kemp, 2004). A decrease in pHi during 
exercise suggests that lactic acid accumulates in exercising muscle cells due to anaerobic 
glycolysis (Kemp, 2004; Sapega et al., 1987; Taylor et al., 1983). The line width frequently 
increased and the Pi peak often split during exercise in patients, suggesting that the pH 
among muscle fibers is heterogeneous, and supporting the suggestion that this phenomenon 
reflects metabolic heterogeneity among muscle fiber types (Vandenborne et al., 1993). 
The H+ and lactate produced can either be buffered and removed intracellularly or released 
to the interstitium. Several transport systems as well as muscle buffering remove H+ during 
intense skeletal muscle contraction. Buffers include free Pi, PCr and histidine residues in 
both proteins and some dipeptides, and the capacity of such buffers is decreased by high-
intensity exercise via a decrease in protein buffering (Bishop et al., 2009). Supplementation 
with ǃ-alanine, which increases muscle protein buffer capacity, attenuates the fall in blood 
pH during exercise (Baguet et al., 2010). Whether BCAA supplementation affects muscle 
buffer capacity remains unclear. 
∆ ∆
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4.2 Plasma BCAA profile in COPD 
Several studies have investigated plasma amino acid profiles in COPD patients (Engelen et 
al., 2000b; Hoffored et al., 1990; Pouw et al., 1998; Yoneda et al., 2001). No specific plasma 
amino acid profile has been identified, probably due to the heterogeneity of disease stages in 
COPD (for example, severity of airflow limitation, hypoxemia, and malnutrition). One study 
of Japanese patients with COPD (Yoneda et al., 2001) found that concentrations of glutamic 
acid and glutamine were elevated, whereas those of BCAAs were decreased except for 
leucine. We have previously investigated plasma amino acid levels in fasting venous blood 
among COPD patients and age-matched healthy subjects, revealing that plasma glutamine 
was elevated without overall changes in BCAAs (Kutsuzawa et al., 2009). The present study 
also showed that levels of plasma BCAA were within normal limits. One previous study 
(Yoneda et al., 2001) demonstrated that decreased concentrations of BCAAs in COPD are 
specifically related to weight loss and decreased muscle mass. Our previous (Kutsuzawa et 
al., 2009) and present studies have shown that the concentration of BCAAs correlated or 
tended to correlate with BMI (r=0.54488, r=0.6099), respectively, so nutritional status relates 
to a low BCAA concentration. However, severity of COPD did not correlate with the 
concentration of BCAAs, since no correlation was seen with FEV1/FEV1pred. 
We measured BCAA levels immediately before the BCAA bout in 6 of 10 patients. Each 
BCAA concentration after BCAA ingestion increased significantly, by more than 3- to 5-fold 
compared to fasting values and to a consistent 2- to 3-fold more than the upper limit of the 
normal range. Another study demonstrated that plasma levels of BCAAs at 2 h after BCAA 
supplementation increase 2-fold after ingesting > 8 g of BCAAs (Hamada et al., 2005). 
Plasma levels of BCAA by the BCAA bout have thus been sufficiently increased. Increased 
plasma levels of BCAAs after administration subsequently enhance BCAA uptake by muscle 
during exercise (MacLean et al., 1996). 
4.3 Plasma BCAAs and muscle energy metabolism 
We have previously reported that plasma BCAA (leucine, isoleucine, valine) concentrations 
correlate with both intracellular pH and the PCr index during exercise (Kutsuzawa et al., 
2009). The present study also showed the relationship between muscle pH and leucine 
(r=0.6713, p<0.05). Total BCAAs tended to correlate with muscle pH (r=0.6015, p<0.1). A 
previous study (Doi et al., 2004) investigated muscle energy metabolism in patients with 
liver cirrhosis accompanied by low plasma BCAA concentrations using 31P-MRS and found 
an acidic pHi during exercise.  
Low plasma BCAA concentrations might affect lactate metabolism through two 
mechanisms. Firstly, BCAAs expand the pool of TCA cycle intermediates (Rutten et al., 
2005; Wagenmakers, 1998) and react with ǂ-ketoglutarate to produce branched-chain ǂ-keto 
acids and glutamic acid in the presence of BCAA aminotransferase (Vandenborne et al., 
1993; Wagenmakers, 1998):  
BCAA + ǂ-ketoglutarate ↔ branched-chain ǂ-keto acids + glutamic acid 
BCAAs would therefore affect intracellular glutamic acid concentrations. During the first 
minutes of exercise, glutamic acid generates TCA cycle intermediates via the alanine 
aminotransferase reaction in skeletal muscle (Rutten et al., 2005):  
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pyruvate + glutamic acid → alanine + ǂ-ketoglutarate 
The accumulated pyruvate can generate alanine through this reaction instead of lactate 
during exercise. Engelen et al. discovered that glutamic acid concentrations in the 
quadriceps femoris muscles of COPD patients are reduced and might relate to a reduced 
lactic threshold (Engelen et al., 2000a).  
Secondly, BCAAs can be oxidized during moderate to heavy exercise. Several studies have 
reported that endurance exercise activates the branched-chain ǂ-keto acid dehydrogenase 
(BCKDH) complex, which catalyzes branched-chain ǂ-keto acid to form coenzyme A 
compounds in human and rat skeletal muscle (Shimomura et al., 1995; Wagenmakers et al., 
1989). Shimomura et al. (Shimomura et al., 1993) reported that activity of the BCKDH 
complex increases in rat hindlimb muscles after 5 min of electrically induced contraction. 
Rates of leucine oxidation were almost double from rest to moderate intensity in healthy 
individuals performing steady-state exercise (Lamont et al., 2001). The oxidation of BCAAs 
does not relate to glycolysis or produce lactate. This mechanism might also explain the 
correlation between pHi and total BCAA after exercise. 
4.4 Effects of amino acid supplementation on patients with COPD 
The effects of BCAA ingestion before and/or after exercise on muscle damage and on 
muscle metabolism have been investigated in athletes since the 1990s. Several studies 
have demonstrated that BCAA supplementation attenuates the increase in blood lactate 
dehydrogenase (Coombes et al., 2000; Koba et al., 2007) and creatine kinase (Coombes et 
al., 2000) after prolonged exercise. Another study has shown that supplementation with 
amino acids including BCAAs attenuates delayed-onset muscle soreness (Nosaka et al., 
2006). These findings suggested that BCAAs attenuate the degree of exercise-induced 
muscle damage. 
Intense muscle activity generates intracellular protons and lactate accumulation. Several 
investigators have studied the effects of BCAA supplementation on lactate accumulation 
during exercise (Blomstrand et al., 1996; De Palo et al., 2001; MacLean et al., 1996; 
Matsumoto et a., 2009; Vukovich et al., 1992) in healthy subjects and athletes. MacLean et al. 
(MacLean et al., 1996) examined the effects of a large oral dose (308 mg/kg) of BCAAs on 
muscle amino acid metabolism during 90 min of dynamic knee extensor exercise. They 
reported that long-term exercise after BCAA administration resulted in significantly greater 
muscle NH3, alanine and glutamine levels, as well as lower lactate production. Matsumoto 
et al. (Matsumoto et al., 2009) studied the effects of BCAA supplementation on the lactate 
threshold during incremental exercise. They demonstrated that BCAA ingestion 
immediately before an incremental exercise test after 6 days of BCAA supplementation 
increased oxygen uptake and workload at the lactate threshold, the onset of blood lactate 
accumulation. Blomstrand et al. reported a smaller decrease in muscle glutamic acid levels 
in healthy volunteers who consumed BCAAs and then performed a prolonged submaximal 
exercise test when compared to a control group (Blomstrand et al., 1996). 
Supplementation with amino acids, particularly BCAAs and/or glutamic acid, should 
increase exercise capacity in COPD patients, as this capacity may be affected by altered 
muscle and plasma amino acid profiles. A small number of studies have examined 
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supplementation with BCAAs or glutamic acid during exercise in COPD patients. Menier et 
al. studied the effects of BCAA administration to COPD patients during rehabilitation and 
showed no effects of BCAA supplementation on maximal oxygen uptake or maximal work 
(Menier et al., 2001). Rutten et al. studied the metabolic and functional effects of glutamic 
acid intake in COPD patients. Oral glutamic acid ingestion (30 mg/kg body weight every 20 
min for 80 min) did not increase muscle glutamic acid concentration or reduce plasma 
lactate levels in COPD patients or healthy controls (Rutten et al., 2008). 
The effects of a single administration of BCAAs on muscle energy metabolism in COPD 
patients have not been investigated. The present study showed that BCAA ingestion 
attenuated ∆pHi and ∆PCr/(PCr+Pi) at the end of exercise compared with the control 
bout. The findings suggested that BCAA supplementation before exercise could increase 
oxidative phosphorylation and decrease lactate production, then attenuate acidosis in 
exercising muscle in COPD patients. We have previously investigated the effects of BCAA 
ingestion on muscle pH during similar repeated bouts of short-term (3-min) exercise in 
healthy young participants (Kutsuzawa et al., 2011). The pHi at the second exercise bout 
without BCAA ingestion was significantly decreased compared with the first bout. In 
contrast, neither pHi after 3 min of exercise nor ∆pHi differed significantly between the 
first and second exercise bouts after BCAA ingestion in healthy participants. Effects of 
BCAA ingestion on muscle pH may be intense in COPD patients, probably due to low 
BCAA concentrations. Muscle energy metabolism might be affected by BCAAs during 
exercise acting as an energy source and as substrates that expand the pool of TCA cycle 
intermediates. 
Patients with COPD frequently develop hypoxemia at rest and/or during exercise, which 
can influence muscle energy metabolism. PaO2 during exercise was not evaluated in the 
present study, although PaO2 at rest ranged from 67 to 90 mmHg. Our previous study 
evaluated PaO2 during the same hand-grip exercise in COPD patients, finding no 
significant decrease during exercise (Kutsuzawa et al., 1992). This suggests that reduced 
oxygen availability might not contribute to lactate accumulation in a control bout in 
COPD patients. 
4.5 Limitations of study 
The present study did not investigate muscle energy metabolism during two consecutive 
short-term bouts of exercise with a 1-h interval without BCAA supplementation. We 
previously studied the effects of a single administration of BCAAs on muscle pH during 
repeated short-term exercise (with or without BCAAs) in healthy young males 
(Kutsuzawa et al., 2011). In that study, healthy individuals performed repeated hand-grip 
exercises that consisted of the same weight, same distance, and double the frequency of 
the present study to induce low muscle pH. All participants who did not take BCAAs 
showed a pHi at completion of the second bout that was significantly decreased 
compared to that of the first bout. These findings suggested that the protocol resulted in 
decreased pHi at the end of the second bout of exercise as compared with the first bout. 
Therefore, pHi and PCr/(PCr+Pi) at the end of the second bout of hand-grip exercise in 
the present study might have been decreased. 
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This study did not measure concentrations of amino acids in muscle. Glutamic acid and 
BCAAs are taken up by skeletal muscle after consuming meals containing protein and the 
carbon skeletons are used for de novo glutamine synthesis (Wagenmakers, 1998). A few 
studies (Pouw et al., 1998; Engelen et al., 2000b) have measured concentrations of muscle 
amino acids in patients with COPD. Pouw et al. (Pouw et al., 1998) reported that levels of 
BCAAs in plasma and muscle do not differ between patients with COPD and healthy 
individuals. However, Engelen et al. (Engelen et al., 2000b) showed that plasma and muscle 
levels of leucine and isoleucine are significantly decreased in COPD subtypes with 
emphysema, indicating that leucine metabolism is altered in COPD patients. Both studies 
demonstrated a decrease in glutamic acid in muscles in such patients. Muscle concentrations 
of glutamic acid and BCAAs might thus be decreased in patients with COPD and low 
plasma BCAA concentrations. 
Furthermore, we did not measure plasma concentrations of lactate, because the magnet in 
our MR equipment was too narrow to collect venous blood from the exercising forearm 
during exercise. We also did not determine whether attenuation of metabolic acidosis in 
muscle resulted in a decrease in plasma lactate levels. However, the present exercise model 
involved a small muscle mass, which produced only limited changes in arterial H+ and 
lactate concentrations. 
5. Conclusions 
BCAA ingestion before a second bout of hand-grip exercise in patients with COPD resulted 
in a significant decrease in ∆pHi and ∆PCr/(PCr+Pi) at the end of the second bout of 
exercise. These findings suggest that BCAAs can help to prevent metabolic acidosis in 
exercising muscle among COPD patients, probably by increasing oxidative capacity and by 
decreasing lactate production. BCAA ingestion should thus improve exercise capacity in 
COPD patients. 
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